We specialize in product licensing of NDA (505B1 and B2) assets from preclinical through to approved products. The portfolio includes US companies with approved products looking for licensing partners outside of the US (Europe, Asia, Middle East and Africa) and European partners looking for US partners.
The service consists of identifying of potential partners, developing short non-confidential teasers, coordinating confidentiality agreements, setting up of the data room and facilitate the closing of the deal.